News

Filter

Current filters:

LicensingAblynx

1 to 9 of 12 results

Second research deal with Merck & Co for Ablynx

Second research deal with Merck & Co for Ablynx

03-02-2014

Belgian drugmaker Ablynx has entered into a second research collaboration and licensing agreement with…

AblynxLicensingMerck & CoOncologyPharmaceuticalResearch

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

18-10-2013

Ablynx has granted an exclusive license to Eddingpharm to develop and commercialize its anti-RANKL Nanobody,…

AblynxAsia-PacificEddingpharmLicensingPharmaceuticalWomen's Health

Ablynx and AbbVie sign deal over rheumatoid arthritis nanobody

Ablynx and AbbVie sign deal over rheumatoid arthritis nanobody

23-09-2013

Belgian drug developer Ablynx and US drugmaker AbbVie have entered into a global license agreement to…

AbbVieAblynxAnti-Arthritics/RheumaticsEuropeLicensingPharmaceutical

Briefs: Ablynx inks research deal with Spirogen; Solent Pharma debuts

25-02-2013

Belgium drug developer Ablynx (Euronext Brussels: ABLX]) has entered into a research collaboration with…

AblynxGenericsidebenoneIdecortexLicensingMarkets & MarketingNeurologicalOncologyPharmaceuticalResearchSolent PharmaSpirogen

Algeta and Ablynx collaborate on tumor-targeting Nanobodies

22-11-2012

Norway-based Algeta (OSE: ALGETA) and Belgian firm Ablynx (Euronext Brussels: ABLX) have entered a research…

AblynxAlgetaBiotechnologyLicensingNanobodiesNanobodyOncologyResearch

Merck & Co in Nanobody deal with Ablynx; J&J and Astellas join forces on RA

02-10-2012

US pharma giant Merck & Co (NYSE: MRK) has entered into a collaboration with Belgium's Ablynx (Euronext…

AblynxAnti-Arthritics/RheumaticsASPO15KAstellas PharmaBiotechnologyJohnson & JohnsonLicensingMerck & CoPharmaceutical

Ablynx extends Nanobody deal with Boehringer

21-03-2012

Belgian drug developer Ablynx (Euronext Brussels: ABLX) yesterday announced a two-year extension of the…

AblynxBiotechnologyBoehringer IngelheimImmunologicalsLicensingOncologyPharmaceuticalRespiratory and Pulmonary

Merck Serono expands osteoarthritis collaboration with Ablynx

09-11-2011

Merck Serono, a division of Germany’s Merck KGaA (MRK: DE) has entered into a third agreement with…

AblynxAnti-Arthritics/RheumaticsLicensingMerck SeronoPharmaceuticalResearch

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top